Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 481 to 492 of 492 entries
Sorted by: Best Match Show Resources per page
Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals.

BMJ quality & safety

Chopra V, O'Malley M, Horowitz J, Zhang Q, McLaughlin E, Saint S, Bernstein SJ, Flanders S.
PMID: 33782091
BMJ Qual Saf. 2022 Jan;31(1):23-30. doi: 10.1136/bmjqs-2021-013015. Epub 2021 Mar 29.

BACKGROUND: The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) provides evidence-based criteria for peripherally inserted central catheter (PICC) use. Whether implementing MAGIC improves PICC appropriateness and reduces complications is unknown.METHODS: A quasiexperimental study design to implement MAGIC in 52...

Cite
Chopra V, O'Malley M, Horowitz J, et al. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ Qual Saf. 2021;31(1):23-30doi: 10.1136/bmjqs-2021-013015.
Chopra, V., O'Malley, M., Horowitz, J., Zhang, Q., McLaughlin, E., Saint, S., Bernstein, S. J., & Flanders, S. (2022). Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ quality & safety, 31(1), 23-30. https://doi.org/10.1136/bmjqs-2021-013015
Chopra, Vineet, et al. "Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals." BMJ quality & safety vol. 31,1 (2022): 23-30. doi: https://doi.org/10.1136/bmjqs-2021-013015
Chopra V, O'Malley M, Horowitz J, Zhang Q, McLaughlin E, Saint S, Bernstein SJ, Flanders S. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ Qual Saf. 2022 Jan;31(1):23-30. doi: 10.1136/bmjqs-2021-013015. Epub 2021 Mar 29. PMID: 33782091; PMCID: PMC8685627.
Copy Download .nbib Format: NLM
A 29-year-old male with a long history of atraumatic wrist pain.

Skeletal radiology

Tilden W, Lindsay D, Astrinakis E, Horwitz M, Saifuddin A.
PMID: 33712878
Skeletal Radiol. 2021 Oct;50(10):2125-2126. doi: 10.1007/s00256-021-03743-6. Epub 2021 Mar 12.

No abstract available.

Cite
Tilden W, Lindsay D, Astrinakis E, et al. A 29-year-old male with a long history of atraumatic wrist pain. Skeletal Radiol. 2021;50(10):2125-2126doi: 10.1007/s00256-021-03743-6.
Tilden, W., Lindsay, D., Astrinakis, E., Horwitz, M., & Saifuddin, A. (2021). A 29-year-old male with a long history of atraumatic wrist pain. Skeletal radiology, 50(10), 2125-2126. https://doi.org/10.1007/s00256-021-03743-6
Tilden, William, et al. "A 29-year-old male with a long history of atraumatic wrist pain." Skeletal radiology vol. 50,10 (2021): 2125-2126. doi: https://doi.org/10.1007/s00256-021-03743-6
Tilden W, Lindsay D, Astrinakis E, Horwitz M, Saifuddin A. A 29-year-old male with a long history of atraumatic wrist pain. Skeletal Radiol. 2021 Oct;50(10):2125-2126. doi: 10.1007/s00256-021-03743-6. Epub 2021 Mar 12. PMID: 33712878.
Copy Download .nbib Format: NLM
Ultrasound-guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet-rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial.

PM & R : the journal of injury, function, and rehabilitation

Kirschner JS, Cheng J, Hurwitz N, Santiago K, Lin E, Beatty N, Kingsbury D, Wendel I, Milani C.
PMID: 33644963
PM R. 2021 Dec;13(12):1340-1349. doi: 10.1002/pmrj.12583. Epub 2021 Apr 28.

BACKGROUND: Tendinosis is a chronic degenerative condition. Current research suggests both percutaneous needle tenotomy (PNT) and leukocyte-rich platelet-rich plasma (LR-PRP) may be effective treatments for chronic tendinosis, but no studies have assessed the effectiveness of PNT alone versus PNT...

Cite
Kirschner JS, Cheng J, Hurwitz N, et al. Ultrasound-guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet-rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial. PM R. 2021;13(12):1340-1349doi: 10.1002/pmrj.12583.
Kirschner, J. S., Cheng, J., Hurwitz, N., Santiago, K., Lin, E., Beatty, N., Kingsbury, D., Wendel, I., & Milani, C. (2021). Ultrasound-guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet-rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial. PM & R : the journal of injury, function, and rehabilitation, 13(12), 1340-1349. https://doi.org/10.1002/pmrj.12583
Kirschner, Jonathan S, et al. "Ultrasound-guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet-rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial." PM & R : the journal of injury, function, and rehabilitation vol. 13,12 (2021): 1340-1349. doi: https://doi.org/10.1002/pmrj.12583
Kirschner JS, Cheng J, Hurwitz N, Santiago K, Lin E, Beatty N, Kingsbury D, Wendel I, Milani C. Ultrasound-guided percutaneous needle tenotomy (PNT) alone versus PNT plus platelet-rich plasma injection for the treatment of chronic tendinosis: A randomized controlled trial. PM R. 2021 Dec;13(12):1340-1349. doi: 10.1002/pmrj.12583. Epub 2021 Apr 28. PMID: 33644963.
Copy Download .nbib Format: NLM
It's time to incorporate diversity into our basic science and disease models.

Nature cell biology

Horwitz R, Riley EAU, Millan MT, Gunawardane RN.
PMID: 34845353
Nat Cell Biol. 2021 Dec;23(12):1213-1214. doi: 10.1038/s41556-021-00803-w.

No abstract available.

Cite
Horwitz R, Riley EAU, Millan MT, et al. It's time to incorporate diversity into our basic science and disease models. Nat Cell Biol. 2021;23(12):1213-1214doi: 10.1038/s41556-021-00803-w.
Horwitz, R., Riley, E. A. U., Millan, M. T., & Gunawardane, R. N. (2021). It's time to incorporate diversity into our basic science and disease models. Nature cell biology, 23(12), 1213-1214. https://doi.org/10.1038/s41556-021-00803-w
Horwitz, Rick, et al. "It's time to incorporate diversity into our basic science and disease models." Nature cell biology vol. 23,12 (2021): 1213-1214. doi: https://doi.org/10.1038/s41556-021-00803-w
Horwitz R, Riley EAU, Millan MT, Gunawardane RN. It's time to incorporate diversity into our basic science and disease models. Nat Cell Biol. 2021 Dec;23(12):1213-1214. doi: 10.1038/s41556-021-00803-w. PMID: 34845353.
Copy Download .nbib Format: NLM
Investigation of Cylindrical Piezoelectric and Specific Multi-Channel Circular MEMS-Transducer Array Resonator of Ultrasonic Ablation.

Micromachines

Liou JC, Peng CW, Chen ZX, Horowitz A, Boerner K.
PMID: 33808313
Micromachines (Basel). 2021 Mar 30;12(4). doi: 10.3390/mi12040371.

BACKGROUND: A cylindrical piezoelectric element and a specific multi-channel circular microelectromechanical systems (MEMS)-transducer array of ultrasonic system were used for ultrasonic energy generation and ablation. A relatively long time is required for the heat to be conducted to the...

Cite
Liou JC, Peng CW, Chen ZX, et al. Investigation of Cylindrical Piezoelectric and Specific Multi-Channel Circular MEMS-Transducer Array Resonator of Ultrasonic Ablation. Micromachines (Basel). 2021;12(4)doi: 10.3390/mi12040371.
Liou, J. C., Peng, C. W., Chen, Z. X., Horowitz, A., & Boerner, K. (2021). Investigation of Cylindrical Piezoelectric and Specific Multi-Channel Circular MEMS-Transducer Array Resonator of Ultrasonic Ablation. Micromachines, 12(4), . https://doi.org/10.3390/mi12040371
Liou, Jian-Chiun, et al. "Investigation of Cylindrical Piezoelectric and Specific Multi-Channel Circular MEMS-Transducer Array Resonator of Ultrasonic Ablation." Micromachines vol. 12,4 (2021). doi: https://doi.org/10.3390/mi12040371
Liou JC, Peng CW, Chen ZX, Horowitz A, Boerner K. Investigation of Cylindrical Piezoelectric and Specific Multi-Channel Circular MEMS-Transducer Array Resonator of Ultrasonic Ablation. Micromachines (Basel). 2021 Mar 30;12(4). doi: 10.3390/mi12040371. PMID: 33808313; PMCID: PMC8066577.
Copy Download .nbib Format: NLM
Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals.

BMJ quality & safety

Chopra V, O'Malley M, Horowitz J, Zhang Q, McLaughlin E, Saint S, Bernstein SJ, Flanders S.
PMID: 33782091
BMJ Qual Saf. 2022 Jan;31(1):23-30. doi: 10.1136/bmjqs-2021-013015. Epub 2021 Mar 29.

BACKGROUND: The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC) provides evidence-based criteria for peripherally inserted central catheter (PICC) use. Whether implementing MAGIC improves PICC appropriateness and reduces complications is unknown.METHODS: A quasiexperimental study design to implement MAGIC in 52...

Cite
Chopra V, O'Malley M, Horowitz J, et al. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ Qual Saf. 2021;31(1):23-30doi: 10.1136/bmjqs-2021-013015.
Chopra, V., O'Malley, M., Horowitz, J., Zhang, Q., McLaughlin, E., Saint, S., Bernstein, S. J., & Flanders, S. (2022). Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ quality & safety, 31(1), 23-30. https://doi.org/10.1136/bmjqs-2021-013015
Chopra, Vineet, et al. "Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals." BMJ quality & safety vol. 31,1 (2022): 23-30. doi: https://doi.org/10.1136/bmjqs-2021-013015
Chopra V, O'Malley M, Horowitz J, Zhang Q, McLaughlin E, Saint S, Bernstein SJ, Flanders S. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals. BMJ Qual Saf. 2022 Jan;31(1):23-30. doi: 10.1136/bmjqs-2021-013015. Epub 2021 Mar 29. PMID: 33782091.
Copy Download .nbib Format: NLM
Rapid response system adaptations at 40 US hospitals during the COVID-19 pandemic.

Resuscitation plus

Mitchell OJL, Doran O, Yuriditsky E, Root C, Teran F, Ma K, Shashaty M, Moskowitz A, Horowitz J, Abella BS.
PMID: 33870236
Resusc Plus. 2021 Jun;6:100121. doi: 10.1016/j.resplu.2021.100121. Epub 2021 Apr 12.

BACKGROUND: Management of patients with acute deterioration from novel coronavirus disease of 2019 (COVID-19) has posed a particular challenge for rapid response systems (RRSs) due to increased hospital strain and direct risk of infection to RRS team members.OBJECTIVE: We...

Cite
Mitchell OJL, Doran O, Yuriditsky E, et al. Rapid response system adaptations at 40 US hospitals during the COVID-19 pandemic. Resusc Plus. 2021;6:100121doi: 10.1016/j.resplu.2021.100121.
Mitchell, O. J. L., Doran, O., Yuriditsky, E., Root, C., Teran, F., Ma, K., Shashaty, M., Moskowitz, A., Horowitz, J., & Abella, B. S. (2021). Rapid response system adaptations at 40 US hospitals during the COVID-19 pandemic. Resuscitation plus, 6100121. https://doi.org/10.1016/j.resplu.2021.100121
Mitchell, Oscar J L, et al. "Rapid response system adaptations at 40 US hospitals during the COVID-19 pandemic." Resuscitation plus vol. 6 (2021): 100121. doi: https://doi.org/10.1016/j.resplu.2021.100121
Mitchell OJL, Doran O, Yuriditsky E, Root C, Teran F, Ma K, Shashaty M, Moskowitz A, Horowitz J, Abella BS. Rapid response system adaptations at 40 US hospitals during the COVID-19 pandemic. Resusc Plus. 2021 Jun;6:100121. doi: 10.1016/j.resplu.2021.100121. Epub 2021 Apr 12. PMID: 33870236; PMCID: PMC8041183.
Copy Download .nbib Format: NLM
Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.

Journal of the American Academy of Dermatology

Stoll JR, Willner J, Oh Y, Pulitzer M, Moskowitz A, Horwitz S, Myskowski P, Noor SJ.
PMID: 33940098
J Am Acad Dermatol. 2021 Nov;85(5):1073-1090. doi: 10.1016/j.jaad.2021.04.080. Epub 2021 Apr 30.

Primary cutaneous T-cell lymphomas (CTCLs) are defined as lymphomas with a T-cell phenotype that present in the skin without evidence of systemic or extracutaneous disease at initial presentation. CTCLs other than mycosis fungoides and Sézary syndrome (SS) account for...

Cite
Stoll JR, Willner J, Oh Y, et al. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis. J Am Acad Dermatol. 2021;85(5):1073-1090doi: 10.1016/j.jaad.2021.04.080.
Stoll, J. R., Willner, J., Oh, Y., Pulitzer, M., Moskowitz, A., Horwitz, S., Myskowski, P., & Noor, S. J. (2021). Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis. Journal of the American Academy of Dermatology, 85(5), 1073-1090. https://doi.org/10.1016/j.jaad.2021.04.080
Stoll, Joseph R, et al. "Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis." Journal of the American Academy of Dermatology vol. 85,5 (2021): 1073-1090. doi: https://doi.org/10.1016/j.jaad.2021.04.080
Stoll JR, Willner J, Oh Y, Pulitzer M, Moskowitz A, Horwitz S, Myskowski P, Noor SJ. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis. J Am Acad Dermatol. 2021 Nov;85(5):1073-1090. doi: 10.1016/j.jaad.2021.04.080. Epub 2021 Apr 30. PMID: 33940098.
Copy Download .nbib Format: NLM
Thyroid function control among pregnant women following a therapeutic thyroidectomy.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery

Horowitz G, Ish-Shalom M, Warshavsky A, Stern N, Fliss DM, Comaneshter D, Vinker S.
PMID: 33290623
Clin Otolaryngol. 2021 May;46(3):515-521. doi: 10.1111/coa.13687. Epub 2021 Jan 06.

OBJECTIVES: The aim of this study was to assess the extent of thyroid function control among pregnant women who had previously undergone a therapeutic thyroidectomy.DESIGN: Retrospective cohort study.SETTING: The largest health maintenance organization in Israel.PARTICIPANTS: All female patients who...

Cite
Horowitz G, Ish-Shalom M, Warshavsky A, et al. Thyroid function control among pregnant women following a therapeutic thyroidectomy. Clin Otolaryngol. 2021;46(3):515-521doi: 10.1111/coa.13687.
Horowitz, G., Ish-Shalom, M., Warshavsky, A., Stern, N., Fliss, D. M., Comaneshter, D., & Vinker, S. (2021). Thyroid function control among pregnant women following a therapeutic thyroidectomy. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 46(3), 515-521. https://doi.org/10.1111/coa.13687
Horowitz, Gilad, et al. "Thyroid function control among pregnant women following a therapeutic thyroidectomy." Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery vol. 46,3 (2021): 515-521. doi: https://doi.org/10.1111/coa.13687
Horowitz G, Ish-Shalom M, Warshavsky A, Stern N, Fliss DM, Comaneshter D, Vinker S. Thyroid function control among pregnant women following a therapeutic thyroidectomy. Clin Otolaryngol. 2021 May;46(3):515-521. doi: 10.1111/coa.13687. Epub 2021 Jan 06. PMID: 33290623.
Copy Download .nbib Format: NLM
Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers.

BMJ open

Oliver K, Raut A, Pierre S, Silvera L, Boulos A, Gale A, Baum A, Chory A, Davis NJ, D'Souza D, Freeman A, Goytia C, Hamilton A, Horowitz C, Islam N, Jeavons J, Knudsen J, Li S, Lupi J, Martin R, Maru S, Nabeel I, Pimenova D, Romanoff A, Rusanov S, Schwalbe NR, Vangeepuram N, Vreeman R, Masci J, Maru D.
PMID: 34992113
BMJ Open. 2022 Jan 06;12(1):e053641. doi: 10.1136/bmjopen-2021-053641.

OBJECTIVES: To examine the factors associated with COVID-19 vaccine receipt among healthcare workers and the role of vaccine confidence in decisions to vaccinate, and to better understand concerns related to COVID-19 vaccination.DESIGN: Cross-sectional anonymous survey among front-line, support service...

Cite
Oliver K, Raut A, Pierre S, et al. Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers. BMJ Open. 2022;12(1):e053641doi: 10.1136/bmjopen-2021-053641.
Oliver, K., Raut, A., Pierre, S., Silvera, L., Boulos, A., Gale, A., Baum, A., Chory, A., Davis, N. J., D'Souza, D., Freeman, A., Goytia, C., Hamilton, A., Horowitz, C., Islam, N., Jeavons, J., Knudsen, J., Li, S., Lupi, J., Martin, R., Maru, S., Nabeel, I., Pimenova, D., Romanoff, A., Rusanov, S., Schwalbe, N. R., Vangeepuram, N., Vreeman, R., Masci, J., & Maru, D. (2022). Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers. BMJ open, 12(1), e053641. https://doi.org/10.1136/bmjopen-2021-053641
Oliver, Kristin, et al. "Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers." BMJ open vol. 12,1 (2022): e053641. doi: https://doi.org/10.1136/bmjopen-2021-053641
Oliver K, Raut A, Pierre S, Silvera L, Boulos A, Gale A, Baum A, Chory A, Davis NJ, D'Souza D, Freeman A, Goytia C, Hamilton A, Horowitz C, Islam N, Jeavons J, Knudsen J, Li S, Lupi J, Martin R, Maru S, Nabeel I, Pimenova D, Romanoff A, Rusanov S, Schwalbe NR, Vangeepuram N, Vreeman R, Masci J, Maru D. Factors associated with COVID-19 vaccine receipt at two integrated healthcare systems in New York City: a cross-sectional study of healthcare workers. BMJ Open. 2022 Jan 06;12(1):e053641. doi: 10.1136/bmjopen-2021-053641. PMID: 34992113.
Copy Download .nbib Format: NLM
Complication Rates After Intraoperative Radiation Therapy: Do Applicator Size and Distance to Skin Matter?.

The Journal of surgical research

Jambhekar A, Wong A, Taback B, Rao R, Horowitz D, Connolly E, Wiechmann L.
PMID: 34416416
J Surg Res. 2021 Dec;268:440-444. doi: 10.1016/j.jss.2021.06.078. Epub 2021 Aug 17.

BACKGROUND: Intraoperative radiation therapy (IORT) has gained popularity for early stage breast cancer treatment. Few studies have examined the relationship between complications and both demographic and technical factors. The objective of the current study was to determine if applicator...

Cite
Jambhekar A, Wong A, Taback B, et al. Complication Rates After Intraoperative Radiation Therapy: Do Applicator Size and Distance to Skin Matter?. J Surg Res. 2021;268:440-444doi: 10.1016/j.jss.2021.06.078.
Jambhekar, A., Wong, A., Taback, B., Rao, R., Horowitz, D., Connolly, E., & Wiechmann, L. (2021). Complication Rates After Intraoperative Radiation Therapy: Do Applicator Size and Distance to Skin Matter?. The Journal of surgical research, 268440-444. https://doi.org/10.1016/j.jss.2021.06.078
Jambhekar, Amani, et al. "Complication Rates After Intraoperative Radiation Therapy: Do Applicator Size and Distance to Skin Matter?." The Journal of surgical research vol. 268 (2021): 440-444. doi: https://doi.org/10.1016/j.jss.2021.06.078
Jambhekar A, Wong A, Taback B, Rao R, Horowitz D, Connolly E, Wiechmann L. Complication Rates After Intraoperative Radiation Therapy: Do Applicator Size and Distance to Skin Matter?. J Surg Res. 2021 Dec;268:440-444. doi: 10.1016/j.jss.2021.06.078. Epub 2021 Aug 17. PMID: 34416416.
Copy Download .nbib Format: NLM
Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia.

Cancer cell

Konishi Y, Sklavenitis-Pistofidis R, Yue H, Ferrari F, Redd RA, Lightbody ED, Russo M, Perry J, Horowitz E, Justis AV, Shayegh NA, Savell A, Prescott J, Varmeh S, Nowak RP, Hamilton M, Auclair D, Marinac CR, Trippa L, Fischer ES, Ghobrial IM.
PMID: 34895486
Cancer Cell. 2022 Jan 10;40(1):6-8. doi: 10.1016/j.ccell.2021.12.003. Epub 2021 Dec 09.

No abstract available.

Cite
Konishi Y, Sklavenitis-Pistofidis R, Yue H, et al. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer Cell. 2021;40(1):6-8doi: 10.1016/j.ccell.2021.12.003.
Konishi, Y., Sklavenitis-Pistofidis, R., Yue, H., Ferrari, F., Redd, R. A., Lightbody, E. D., Russo, M., Perry, J., Horowitz, E., Justis, A. V., Shayegh, N. A., Savell, A., Prescott, J., Varmeh, S., Nowak, R. P., Hamilton, M., Auclair, D., Marinac, C. R., Trippa, L., Fischer, E. S., & Ghobrial, I. M. (2022). Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer cell, 40(1), 6-8. https://doi.org/10.1016/j.ccell.2021.12.003
Konishi, Yoshinobu, et al. "Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia." Cancer cell vol. 40,1 (2022): 6-8. doi: https://doi.org/10.1016/j.ccell.2021.12.003
Konishi Y, Sklavenitis-Pistofidis R, Yue H, Ferrari F, Redd RA, Lightbody ED, Russo M, Perry J, Horowitz E, Justis AV, Shayegh NA, Savell A, Prescott J, Varmeh S, Nowak RP, Hamilton M, Auclair D, Marinac CR, Trippa L, Fischer ES, Ghobrial IM. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer Cell. 2022 Jan 10;40(1):6-8. doi: 10.1016/j.ccell.2021.12.003. Epub 2021 Dec 09. PMID: 34895486; PMCID: PMC8654583.
Copy Download .nbib Format: NLM
Showing 481 to 492 of 492 entries